Media, Sera and Reagents Global Market Segmentation and key Players Analysis 2022

PUNE , INDIA, February 14, 2018 /EINPresswire.com/ -- Report Scope:
Cell culture products are used from the point of drug discovery through the process of drug development. Cell culture products are used mainly for research purposes, for production of biopharmaceuticals, and for educational purposes. This report focuses on the global market for media, sera and reagent products used in the cell culture industry and discusses the applications in various arenas of biomedical and life science research. The report addresses the whole market for cell culture including the research segment, production segment, contract segment, and “others” segment, which includes the in vitro diagnostics and educational sector.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2820078-global-markets-for-media-sera-and-reagents-in-biotechnology

The scope of the study is worldwide. Current market dynamics, market drivers, restraints, trends, regulatory issues, and strategic developments are discussed in the report. In the regional analysis, the report identifies and analyzes market size and forecasts for the U.S., Europe and emerging markets. The emerging markets for media, sera and reagents in biotechnology include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, and other countries.

Also included in the report are relevant patent analyses and comprehensive profiles of companies that lead the market for media, sera and reagents in the cell culture industry. A few prominent players in this industry are Thermo Fisher Scientific, Merck KGaA, GE Healthcare Life Sciences, BD Biosciences, and Corning Inc.

Report Includes:
- An overview of the global markets and technologies for media, sera and reagents used in biotechnology.
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021.
- Information on different types of cell cultures and products from cell culture technology as well as the advantages and disadvantages for the use of various types of media.
- Detailed analysis of the cell culture industry's structure.
- Discussion covering the applications of cell culture technology with an emphasis on usage in the research, production, and contract segments.
- Profiles of major players in the media, sera, and reagents industry.

Key Players
ADVANCED BIOTECHNOLOGIES INC.
AFFYMETRIX (ACQUIRED BY THERMO FISHER)
AKRON BIOTECHNOLOGY LLC
AMRESCO LLC
ATHENA ENVIRONMENTAL SCIENCES INC.
ATLANTA BIOLOGICALS INC.
BD BIOSCIENCES
BIORECLAMATIONIVT
BOVOGEN BIOLOGICALS PTY LTD.
CAISSON LABORATORIES
CELL APPLICATIONS INC.
CELL CULTURE TECHNOLOGIES LLC
CORNING INC.
EMD MILLIPORE
EQUITECH-BIO INC.
GE HEALTHCARE LIFE SCIENCES
GEMINI BIO-PRODUCTS
GENEX INDIA BIOSCIENCE PVT. LTD.
HIMEDIA LABORATORIES
IRVINE SCIENTIFIC
J R SCIENTIFIC INC.
LABMATE (ASIA) PVT. LTD.
LONZA GROUP LTD.
MEDIATECH INC.
MEDOX BIOTECH INDIA PVT. LTD.
MP BIOMEDICALS LLC
PEPROTECH INC.
PROMOCELL GMBH
QUALITY BIOLOGICAL INC.

Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Contributions of the Study and For Whom
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Terminology
Historical Events in Cell Culture Development
Types of Cell Culture
Cell Line, Cell Strain and Transformed Cell Lines
Cell Culture Contamination
Quality-Control Considerations in Cell Culture
Basic Requirements of Cell Cultures
Cell culture
Culture medium/Media
Cell line
Prokaryotes
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820078-global-markets-for-media-sera-and-reagents-in-biotechnology

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here